#None #Healthcare AI #Patient Care #Concurrence

Amigo Transforms into Concurrence: Embracing AI for Smarter Healthcare

In a significant move that redefines its mission, Amigo, a pioneering platform in clinical AI, has announced its rebranding to Concurrence. This transition is not merely a change in name but symbolizes the company’s broader ambition to develop advanced data and AI systems that can be utilized by health organizations, biopharma companies, and public health agencies to optimize patient care.

A Shift in Perspective

According to Ali Khokhar, the CEO of Concurrence, the term 'Concurrence' embodies the concept of reaching an agreement in judgment or opinion. He emphasizes that determining what constitutes the best care for a patient requires empirical evidence that is accessible to all stakeholders involved in the healthcare process.

The driving force behind Concurrence's new identity lies in its goal to unify the varied data generated across the healthcare spectrum into a cohesive system. This integration forms the Health World Model, which provides clinicians and AI algorithms with comprehensive patient context, enhancing the decision-making process at every care stage.

Building a Better Framework

Concurrence is actively collaborating with prominent health institutions to consolidate their data, allowing for a more streamlined and effective approach to patient management. By leveraging AI-driven workflows, Concurrence has set out to enhance the efficiency of healthcare delivery, capturing critical interactions between patients and healthcare providers in minute detail. This effort extends beyond traditional patient care to include areas such as medication management and clinical decision support.

At the core of the Concurrence system are the Patient Trajectories, a methodical approach that identifies optimal pathways from medical interventions to outcomes. This means that healthcare systems can leverage insights that detail what strategies are most likely to succeed for specific patient demographics. By basing these insights on robust evidence, Concurrence aims to refine operational practices, improve medication adherence for biopharma companies, and enhance overall population health outcomes.

Bridging the Gap in Healthcare

Dr. Jay Shah, the Chief Medical Officer at Concurrence and a former Chief of Medical Staff at Stanford Health Care, highlights a critical issue in the healthcare sector—the lack of comprehensive data capture during patient encounters. He points out that, historically, healthcare has often been viewed through the lens of brief patient interactions, neglecting the extensive data that influences health outcomes outside of these encounters.

Concurrence addresses this gap by ensuring that the context surrounding each care decision is recorded, ultimately allowing every interaction to contribute to improved future care. This iterative learning process is set to enhance not just individual patient experiences but also the overarching healthcare landscape.

About Concurrence

Formerly known as Amigo, Concurrence stands as a forward-thinking data and AI company dedicated to cultivating empirical evidence in healthcare. By aligning with various health systems, biopharma enterprises, and public health agencies, Concurrence seeks to harmonize healthcare data while deploying AI to learn continuously from each care interaction. Their enterprise solutions are designed to integrate seamlessly with popular Electronic Health Records (EHR) systems such as Epic, Oracle Health, and Athenahealth, ensuring both compliance with HIPAA and GDPR regulations.

To date, Concurrence's platform has facilitated over ten million patient interactions, marking a significant milestone in its journey towards transforming healthcare. For additional information on their services and mission, interested parties can visit www.concurrence.com.

With its ambitious rebranding, Concurrence hopes to lead the charge in making healthcare not only more efficient but also deeply informed by data, thereby improving patient outcomes on a larger scale.